# reload+after+2024-01-21 06:35:46.583685
address1§Alderley Park
address2§Alderley Edge Cheshire
city§Macclesfield
zip§SK10 4TG
country§United Kingdom
website§https://www.bivictrix.com
industry§Biotechnology
industryKey§biotechnology
industryDisp§Biotechnology
sector§Healthcare
sectorKey§healthcare
sectorDisp§Healthcare
longBusinessSummary§BiVictriX Therapeutics Plc, a biotechnology company, engages in the development of cancer therapies in the United Kingdom. The company develops Bi-Cygni therapeutics, which are selective for cancer types. Its lead program is BVX001, focuses on acute myeloid leukaemia, as well as develops BVX002 and BVX003 for various blood cancers and solid tumours. BiVictriX Therapeutics Plc was founded in 2016 and is headquartered in Macclesfield, the United Kingdom.
fullTimeEmployees§17
companyOfficers§[{'maxAge': 1, 'name': 'Ms. Tiffany Jane Thorn BSc. MSc., M.Sc.', 'age': 35, 'title': 'CEO & Executive Director', 'yearBorn': 1988, 'fiscalYear': 2022, 'totalPay': 192500, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Adrian  Howd Ph.D.', 'age': 51, 'title': 'Chief Business Officer & CFO', 'yearBorn': 1972, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Simon  Wallwork', 'title': 'Secretary', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§-0.615
currency§GBp
forwardEps§-25.78
exchange§LSE
quoteType§EQUITY
shortName§BIVICTRIX THERAPEUTICS PLC ORD 
longName§BiVictriX Therapeutics Plc
firstTradeDateEpochUtc§1628665200
timeZoneFullName§Europe/London
timeZoneShortName§GMT
uuid§32acedf7-7ab1-3e05-b854-933f0543dc93
messageBoardId§finmb_417339681
targetHighPrice§66.0
targetLowPrice§66.0
targetMeanPrice§66.0
targetMedianPrice§66.0
recommendationMean§2.0
recommendationKey§buy
numberOfAnalystOpinions§1
quickRatio§6.851
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
